CARB-X

CARB-X (Combating Antibiotic Resistant Bacteria Biopharmaceutical Accelerator) is a global organization that funds and supports the development of new antibiotics, vaccines, and diagnostics to fight drug-resistant infections. It brings together governments, funders, and industry partners to accelerate cutting-edge research, helping to bring vital medical tools to market quickly. By investing in innovative solutions, CARB-X aims to address the critical and growing threat of bacteria resistant to existing treatments, safeguarding public health and ensuring effective options remain available for bacterial infections.